Answer questions and earn CME/CNE Patients with breast cancer commonly use
complementary and integrative therapies as supportive care during cancer treatment and to …

This review provides an update on the current clinical and preclinical understanding of
chemotherapy induced peripheral neuropathy (CIPN). The overview of the clinical syndrome …

Purpose The current epidemic of prescription opioid misuse has increased scrutiny of
postoperative opioid prescribing. Some 6% to 8% of opioid-naïve patients undergoing …

Neurotoxic anticancer drugs, such as platinum-based anticancer drugs, taxanes, vinca
alkaloids, and proteasome/angiogenesis inhibitors are responsible for chemotherapy …

Purpose Chemotherapy-induced peripheral neuropathy (CIPN) may persist after treatment
ends and may lead to functional decline and falls. This study compared objective and self …

Chemotherapy-induced pain is a dose-limiting condition that affects 30% of patients
undergoing chemotherapy. We found that gut microbiota promotes the development of …

In 2016, a number of important milestones for cancer survivorship were ushered in. It was
the 30-year anniversary of the creation of the National Coalition for Cancer Survivorship …

Patients treated with platinum-based chemotherapy frequently experience neurotoxic
symptoms, which may lead to premature discontinuation of therapy. Despite discontinuation …

Opioids are first-line drugs for moderate to severe acute pain and cancer pain. However,
these medications are associated with severe side effects, and whether they are efficacious …

Background Antidepressants are widely used in the treatment of chronic pain. Applied doses
are lower than those needed to unfold an antidepressive effect. While efficacy of …